Monodesmethyl sumatriptan(CAT: I032621), also known as desmethyl sumatriptan or 5-HT1B/1D receptor agonist BIBN4096BS, is a metabolite of sumatriptan, a medication commonly used for the treatment of migraines. Monodesmethyl sumatriptan retains the pharmacological activity of sumatriptan and acts as a selective agonist for serotonin (5-HT1B/1D) receptors. By binding to these receptors, monodesmethyl sumatriptan helps to constrict blood vessels and reduce inflammation, thereby relieving the symptoms of migraines. Its activity as a selective serotonin receptor agonist makes it an effective option for the management of acute migraine attacks..
| Catalog Number | I032621 |
| CAS Number | 88919-51-1 |
| Synonyms | Monodesmethyl sumatriptan |
| Molecular Formula | C13H19N3O2S |
| Purity | 98 |
| Solubility | Soluble in DMSO |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 1H-Indole-5-methanesulfonamide, N-methyl-3-(2-(methylamino)ethyl)- |
| InChI | InChI=1S/C13H19N3O2S/c1-14-6-5-11-8-16-13-4-3-10(7-12(11)13)9-19(17,18)15-2/h3-4,7-8,14-16H,5-6,9H2,1-2H3 |
| InChIKey | YDTVAJYBEHCVJY-UHFFFAOYSA-N |
| SMILES | O=S(CC1=CC2=C(NC=C2CCNC)C=C1)(NC)=O |
